Impact of inorganicnutrients onmaintenance of genomic stability

Environmental and Molecular Mutagenesis

Volumn 50, Issue 5, 2009, Pages 349-360

  Cheng, Wen Hsing ^a  

^a UNIVERSITY OF MARYLAND   (United States)

Author keywords

Cancer; Copper; Genome stability; Iron; Selenium; Zinc

Indexed keywords

ATM PROTEIN; COPPER; COPPER ZINC SUPEROXIDE DISMUTASE; IRON; REACTIVE OXYGEN METABOLITE; RNA BINDING PROTEIN; SELENIUM; TRACE ELEMENT; ZINC;

CARCINOGENESIS; CELL STRESS; CHEMICAL REACTION; CHROMOSOMAL INSTABILITY; DNA DAMAGE; DNA REPAIR; DNA STRAND BREAKAGE; FANCONI ANEMIA; GENOMIC INSTABILITY; HUMAN; INORGANIC NUTRIENT; NONHUMAN; OXIDATION; REVIEW; ANIMAL; BIOLOGICAL MODEL; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; GENETICS; NEOPLASM;

ANIMALS; COPPER; GENOMIC INSTABILITY; HUMANS; IRON; MODELS, BIOLOGICAL; NEOPLASMS; SELENIUM; TRACE ELEMENTS; ZINC;

EID: 67549123409     PISSN: 08936692     EISSN: 10982280     Source Type: Journal    
DOI: 10.1002/em.20489     Document Type: Review

References (124)

1. Abnet CC, Lai B, Qiao YL, Vogt S, Luo XM, Taylor PR, Dong ZW, Mark SD, Dawsey SM. 2005. Zinc concentration in esophageal biopsy specimens measured by x-ray fluorescence and esophageal cancer risk. J Natl Cancer Inst 97:301-306. (Pubitemid 40310278)
2. Afanas'ev IB. 2006. Interplay between superoxide and nitric oxide in thalassemia and Fanconi's anemia. Hemoglobin 30:113-118.
3. Ames BN. 2001. DNA damage from micronutrient deficiencies is likely to be a major cause of cancer. Mutat Res 475:7-20. (Pubitemid 32284938)
4. Ames BN, Wakimoto, P. 2002. Are vitamin and mineral deficiencies a major cancer risk? Nat Rev Cancer 2:694-704.
5. Asmuss M, Mullenders LH, Eker A, Hartwig A. 2000. Differential effects of toxic metal compounds on the activities of Fpg and XPA, two zinc finger proteins involved in DNA repair. Carcinogenesis 21:2097-2104. (Pubitemid 30845323)
6. Bal W, Schwerdtle T, Hartwig A. 2003. Mechanism of nickel assault on the zinc finger of DNA repair protein XPA. Chem Res Toxicol 16:242-248. (Pubitemid 36245874)
7. Barch DH, Fox CC. 1987. Dietary zinc deficiency increases the methylbenzylnitrosamine- induced formation of O6-methylguanine in the esophageal DNA of the rat. Carcinogenesis 8:1461-1464.
8. Bartek J, Lukas C, Lukas J. 2004. Checking on DNA damage in S phase. Nat Rev Mol Cell Biol 5:792-804.
9. Bartkova J, Horejsi Z, Koed K, Kramer A, Tort F, Zieger K, Guldberg P, Sehested M, Nesland JM, Lukas C, Orntoft T, Lukas J, Bartek J. 2005. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 434:864-870. (Pubitemid 40558993)
10. Bartkova J, Rezaei N, Liontos M, Karakaidos P, Kletsas D, Issaeva N, Vassiliou LF, Kolettas E, Niforou K, Zoumpourlis VC, Takaoka M, Nakagawa H, Tort F, Fugger K, Johansson F, Sehested M, Andersen CL, Dyrskjot L, OØrntoft T, Lukas J, Kittas C, Helleday T, Halazonetis TD, Bartek J, Gorgoulis VG. 2006. Oncogeneinduced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 444:633-637. (Pubitemid 44864442)
11. Beck MA, Esworthy RS, Ho YS, Chu FF. 1998. Glutathione peroxidase protects mice from viral-induced myocarditis. FASEB J 12:1143-1149. (Pubitemid 28418944)
12. Bleijlevens B, Shivarattan T, Sedgwick B, Rigby SE, Matthews SJ. 2007. Replacement of non-heme Fe(II) with Cu(II) in the alphaketoglutarate dependent DNA repair enzyme AlkB: Spectroscopic characterization of the active site. J Inorg Biochem 101:1043-1048. (Pubitemid 46901143)
13. Bock A. 2000. Biosynthesis of selenoproteins-an overview. Biofactors 11:77-78.
14. Bolin CM, Basha R, Cox D, Zawia NH, Maloney B, Lahiri DK, Cardozo-Pelaez F. 2006. Exposure to lead and the developmental origin of oxidative DNA damage in the aging brain. FASEB J 20:788-790. (Pubitemid 46671216)
15. Burk RF. 1991. Molecular biology of selenium with implications for its metabolism. FASEB J 5:2274-2279. (Pubitemid 21892903)
16. Cheng WH, Ho YS, Ross DA, Valentine BA, Combs GF Jr, Lei XG. 1997. Cellular glutathione peroxidase knockout mice express normal levels of selenium-dependent plasma and phospholipid hydroperoxide glutathione peroxidases in various tissues. J Nutr 127:1445-1450. (Pubitemid 27323452)
17. Cheng WH, Ho YS, Valentine BA, Ross DA, Combs GF Jr, Lei XG. 1998. Cellular glutathione peroxidase is the mediator of body selenium to protect against paraquat lethality in transgenic mice. J Nutr 128:1070-1076. (Pubitemid 28317668)
18. Cheng WH, Muftuoglu M, Bohr VA. 2007. Werner syndrome protein: Functions in the response to DNA damage and replication stress in S-phase. Exp Gerontol 42:871-878. (Pubitemid 47268735)
19. Christensen MJ, Cammack PM, Wray CD. 1995. Tissue specificity of selenoprotein gene expression in rats. J Nutr Biochem 6:367-372.
20. Christudoss P, Selvakumar R, Pulimood AB, Fleming JJ, Mathew G. 2008. Tissue zinc levels in precancerous tissue in the gastrointestinal tract of azoxymethane (AOM)-treated rats. Exp Toxicol Pathol 59:313-318. (Pubitemid 351288522)
21. Clark LC, Combs GF Jr, Turnbull BW, Slate EH, Chalker DK, Chow J, Davis LS, Glover RA, Graham GF, Gross EG, Krongrad A, Lesher JL Jr, Park HK, Sanders BB Jr, Smith CL, Taylor JR. 1996. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA 276:1957-1963.
22. Cleaver JE. 2005. Cancer in xeroderma pigmentosum and related disorders of DNA repair. Nat Rev Cancer 5:564-573. (Pubitemid 40942832)
23. Combs GF Jr, Gray WP. 1998. Chemopreventive agents: Selenium. Pharmacol Ther 79:179-192.
24. Conte D, Narindrasorasak S, Sarkar B. 1996. In vivo and in vitro ironreplaced zinc finger generates free radicals and causes DNA damage. J Biol Chem 271:5125-5130.
25. Cousins RJ, Liuzzi JP, Lichten LA. 2006. Mammalian zinc transport, trafficking, and signals. J Biol Chem 281:24085-24089.
26. Daniel KG, Harbach RH, Guida WC, Dou QP. 2004. Copper storage diseases: Menkes, Wilsons, and cancer. Front Biosci 9:2652-2662.
27. de Haan JB, Bladier C, Lotfi-Miri M, Taylor J, Hutchinson P, Crack PJ, Hertzog P, Kola I. 2004. Fibroblasts derived from Gpx1 knockout mice display senescent-like features and are susceptible to H2O2- mediated cell death. Free Radic Biol Med 36:53-64. (Pubitemid 38068291)
28. Davis CD, Newman S. 2000. Inadequate dietary copper increases tumorigenesis in the Min mouse. Cancer Lett 159:57-62. (Pubitemid 30676214)
29. Demple B, Sung JS. 2005. Molecular and biological roles of Ape1 protein in mammalian base excision repair. DNA Repair (Amst) 4:1442-1449. (Pubitemid 41653305)
30. Deng HX, Hentati A, Tainer JA, Iqbal Z, Cayabyab A, Hung WY, Getzoff ED, Hu P, Herzfeldt B, Roos RP, Warner C, Deng G, Soriano E, Smyth C, Parge HE, Ahmed A, Roses AD, Hallewell R, Pericak-Vance MA, Siddique T. 1993. Amyotrophic lateral sclerosis and structural defects in Cu, Zn superoxide dismutase. Science 261:1047-1051. (Pubitemid 23300865)
31. Dianov GL, Parsons JL. 2007. Co-ordination of DNA single strand break repair. DNA repair 6:454-460. (Pubitemid 46357050)
32. Esworthy RS, Baker MA, Chu FF. 1995. Expression of selenium-dependent glutathione peroxidase in human breast tumor cell lines. Cancer Res 55:957-962.
33. Fischer JL, Lancia JK, Mathur A, Smith ML. 2006. Selenium protection from DNA damage involves a Ref1/p53/Brca1 protein complex. Anticancer Res 26:899-904.
34. Fischer JL, Mihelc EM, Pollok KE, Smith ML. 2007. Chemotherapeutic selectivity conferred by selenium: A role for p53-dependent DNA repair. Mol Cancer Ther 6:355-361. (Pubitemid 46206700)
35. Fong LY, Cheung T, Ho YS. 1988. Effect of nutritional zinc-deficiency on O6-alkylguanine-DNA-methyl-transferase activities in rat tissues. Cancer Lett 42:217-223. (Pubitemid 18263403)
36. Fujimura M, Morita-Fujimura Y, Narasimhan P, Copin JC, Kawase M, Chan PH. 1999. Copper-zinc superoxide dismutase prevents the early decrease of apurinic/apyrimidinic endonuclease and subsequent DNA fragmentation after transient focal cerebral ischemia in mice. Stroke 30:2408-2415. (Pubitemid 29517742)
37. Furuta S, Ortiz F, Zhu-Sun X, Wu HH, Mason A, Momand J. 2002. Copper uptake is required for pyrrolidine dithiocarbamate-mediated oxidation and protein level increase of p53 in cells. Biochem J 365:639-648. (Pubitemid 34864445)
38. Gao J, Zhao N, Knutson MD, Enns CA. 2008. The hereditary hemochromatosis protein HFE, inhibits iron uptake via downregulation of Zip14 in HEPG2 cells. J Biol Chem 283:21462-21468.
39. Ghoshal K, Majumder S, Li Z, Bray TM, Jacob ST. 1999. Transcriptional induction of metallothionein-I and -II genes in the livers of Cu, Zn-superoxide dismutase knockout mice. Biochem Biophys Res Commun 264:735-742.
40. Gille JJ, Wortelboer HM, Joenje H. 1987. Antioxidant status of Fanconi anemia fibroblasts. Hum Genet 77:28-31. (Pubitemid 18011237)
41. Gorgoulis VG, Vassiliou LF, Karakaidos P, Zacharatos P, Kotsinas A, Liloglou T, Venere M, DiTullio Jr RA, Kastrinakis NG, Levy B, Kletsas D, Yoneta A, Herlyn M, Kittas C, Halazonetis TD. 2005. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 434:907-913. (Pubitemid 40559004)
42. Hanahan D, Weinberg RA. 2000. The hallmarks of cancer. Cell 100:57-70.
43. Hegde ML, Hazra TK, Mitra S. 2008. Early steps in the DNA base excision/ single-strand interruption repair pathway in mammalian cells. Cell Res 18:27-47.
44. Henry NL, Dunn R, Merjaver S, Pan Q, Pienta KJ, Brewer G, Smith DC. 2006. Phase II trial of copper depletion with tetrathiomolybdate as an antiangiogenesis strategy in patients with hormone-refractory prostate cancer. Oncology 71:168-175.
45. Hickson ID. 2003. RecQ helicases: Caretakers of the genome. Nat Rev Cancer 3:169-178.
46. Ho E. 2004. Zinc deficiency, DNA damage and cancer risk. J Nutr Biochem 15:572-578. (Pubitemid 39470210)
47. Ho E, Ames BN. 2002. Low intracellular zinc induces oxidative DNA damage, disrupts p53, NFkappa B, AP1 DNA binding, and affects DNA repair in a rat glioma cell line. Proc Natl Acad Sci USA 99:16770-16775. (Pubitemid 36034048)
48. Ho E, Courtemanche C, Ames BN. 2003. Zinc deficiency induces oxidative DNA damage and increases p53 expression in human lung fibroblasts. J Nutr 133:2543-2548. (Pubitemid 36935967)
49. Ho YS, Magnenat JL, Bronson RT, Cao J, Gargano M, Sugawara M, Funk CD. 1997. Mice deficient in cellular glutathione peroxidase develop normally and show no increased sensitivity to hyperoxia. J Biol Chem 272:16644-16651. (Pubitemid 27276497)
50. Hu H, Jiang C, Schuster T, Li GX, Daniel PT, Lu J. 2006. Inorganic selenium sensitizes prostate cancer cells to TRAIL-induced apoptosis through superoxide/p53/Bax-mediated activation of mitochondrial pathway. Mol Cancer Ther 5:1873-1882. (Pubitemid 44323256)
51. Imlay JA. 2003. Pathways of oxidative damage. Annu Rev Microbiol 57:395-418.
52. Inutsuka S, Araki S. 1978. Plasma copper and zinc levels in patients with malignant tumors of digestive organs: Clinical evaluation of the C1/Zn ratio. Cancer 42:626-631. (Pubitemid 8405856)
53. Irons R, Carlson BA, Hatfield DL, Davis CD. 2006. Both selenoproteins and low molecular weight selenocompounds reduce colon cancer risk in mice with genetically impaired selenoprotein expression. J Nutr 136:1311-1317.
54. Ito K, Hirao A, Arai F, Takubo K, Matsuoka S, Miyamoto K, Ohmura M, Naka K, Hosokawa K, Ikeda Y, Suda T. 2006. Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells. Nat Med 12:446-451.
55. Kang YJ. 1999. The antioxidant function of metallothionein in the heart. Proc Soc Exp Biol Med 222:263-273.
56. Khan GN, Merajver SD. 2007. Modulation of angiogenesis for cancer prevention: Strategies based on antioxidants and copper defi- ciency. Curr Pharm Des 13:3584-3590. (Pubitemid 350238929)
57. Killilea DW, Ames BN. 2008. Magnesium deficiency accelerates cellular senescence in cultured human fibroblasts. Proc Natl Acad Sci USA 105:5768-5773. (Pubitemid 351758447)
58. Klungland A, Rosewell I, Hollenbach S, Larsen E, Daly G, Epe B, Seeberg E, Lindahl T, Barnes DE. 1999. Accumulation of premutagenic DNA lesions in mice defective in removal of oxidative base damage. Proc Natl Acad Sci USA 96:13300-13305.
59. Kryukov GV, Castellano S, Novoselov SV, Lobanov AV, Zehtab O, Guigo R, Gladyshev VN. 2003. Characterization of mammalian selenoproteomes. Science 300:1439-1443.
60. Lee DH, Esworthy RS, Chu C, Pfeifer GP, Chu FF. 2006. Mutation accumulation in the intestine and colon of mice deficient in two intracellular glutathione peroxidases. Cancer Res 66:9845-9851. (Pubitemid 44672035)
61. Lee DH, O'Connor TR, Pfeifer GP. 2002. Oxidative DNA damage induced by copper and hydrogen peroxide promotes CG->TT tandem mutations at methylated CpG dinucleotides in nucleotide excision repair-deficient cells. Nucleic Acids Res 30:3566-3573. (Pubitemid 34919212)
62. Li GX, Hu H, Jiang C, Schuster T, Lu J. 2007a. Differential involvement of reactive oxygen species in apoptosis induced by two classes of selenium compounds in human prostate cancer cells. Int J Cancer 120:2034-2043. (Pubitemid 46418385)
63. Li S, Zhou Y, Wang R, Zhang H, Dong Y, Ip C. 2007b. Selenium sensitizes MCF-7 breast cancer cells to doxorubicin-induced apoptosis through modulation of phospho-Akt and its downstream substrates. Mol Cancer Ther 6:1031-1038. (Pubitemid 46554573)
64. Linder MC. 2001. Copper and genomic stability in mammals. Mutat Res 475:141-152.
65. Lippman SM, Klein EA, Goodman PJ, Lucia MS, Thompson IM, Ford LG, Parnes HL, Minasian LM, Gaziano JM, Hartline JA, Parsons JK, Bearden JD III, Crawford ED, Goodman GE, Claudio J, Winquist E, Cook ED, Karp DD, Walther P, Lieber MM, Kristal AR, Darke AK, Arnold KB, Ganz PA, Santella RM, Albanes D, Taylor PR, Probstfield JL, Jagpal TJ, Crowley JJ, Meyskens FL Jr, Baker LH, Coltman CA Jr. 2008. Effect of selenium and vitamin E on risk of prostate cancer and other cancers. JAMA 276:1957-1963.
66. Lowndes SA, Harris AL. 2005. The role of copper in tumour angiogenesis. J Mammary Gland Biol Neoplasia 10:299-310.
67. Lu CY, Lee HC, Fahn HJ, Wei YH. 1999. Oxidative damage elicited by imbalance of free radical scavenging enzymes is associated with large-scale mtDNA deletions in aging human skin. Mutat Res 423:11-21. (Pubitemid 29073645)
68. Lu J, Jiang C, Kaeck M, Ganther H, Vadhanavikit S, Ip C, Thompson H. 1995. Dissociation of the genotoxic and growth inhibitory effects of selenium. Biochem Pharmacol 50:213-219.
69. Madsen E, Gitlin JD. 2007. Copper deficiency. Curr Opin Gastroenterol 23:187-192.
70. Mahabir S, Forman MR, Barerra SL, Dong YQ, Spitz MR, Wei Q. 2007. Joint effects of dietary trace metals and DNA repair capacity in lung cancer risk. Cancer Epidemiol Biomarkers Prev 16:2756-2762. (Pubitemid 351196333)
71. McNeill DR, Narayana A, Wong HK, Wilson DM III. 2004. Inhibition of Ape1 nuclease activity by lead, iron, and cadmium. Environ. Health Perspect 112:799-804. (Pubitemid 38714779)
72. Mukhopadhyay SS, Leung KS, Hicks MJ, Hastings PJ, Youssoufian H, Plon SE. 2006. Defective mitochondrial peroxiredoxin-3 results in sensitivity to oxidative stress in Fanconi anemia. J Cell Biol 175:225-235. (Pubitemid 44631417)
73. Naka K, Tachibana A, Ikeda K, Motoyama N. 2004. Stress-induced premature senescence in hTERT-expressing ataxia telangiectasia fibroblasts. J Biol Chem 279:2030-2037. (Pubitemid 38084474)
74. Nakatsuru Y, Matsukuma S, Nemoto N, Sugano H, Sekiguchi M, Ishikawa T. 1993. O6-methylguanine-DNA methyltransferase protects against nitrosamine-induced hepatocarcinogenesis. Proc Natl Acad Sci USA 90:6468-6472. (Pubitemid 23207234)
75. Nascimento AL, Meneghini R. 1995. Cells transfected with transferrin receptor cDNA lacking the iron regulatory domain become more sensitive to the DNA-damaging action of oxidative stress. Carcinogenesis 16:1335-1338.
76. Nocentini S. 1987. Inhibition of DNA replication and repair by cadmium in mammalian cells. Protective interaction of zinc. Nucleic Acids Res 15:4211-4225.
77. O'Driscoll M, Jeggo PA. 2006. The role of double-strand break repair - insights from human genetics. Nat Rev Genet 7:45-54. (Pubitemid 41828947)
78. Oteiza PL, Olin KL, Fraga CG, Keen CL. 1996. Oxidant defense systems in testes from zinc-deficient rats. Proc Soc Exp Biol Med 213:85-91. (Pubitemid 26331087)
79. Pagano G, Degan P, D'Ischia M, Kelly FJ, Nobili B, Pallardo FV, Youssoufian H, Zatterale A. 2005. Oxidative stress as a multiple effector in Fanconi anaemia clinical phenotype. Eur J Haematol 75:93-100.
80. Pagano G, Zatterale A, Korkina LG. 1999. Mitomycin C-induced DNA damage in Fanconi anemia: Cross-linking or redox-mediated effects? Blood 93:1116-1118.
81. Park SJ, Ciccone SL, Beck BD, Hwang B, Freie B, Clapp DW, Lee SH. 2004. Oxidative stress/damage induces multimerization and interaction of Fanconi anemia proteins. J Biol Chem 279:30053-30059. (Pubitemid 38937926)
82. Pavletich NP, Chambers KA, Pabo CO. 1993. The DNA-binding domain of p53 contains the four conserved regions and the major mutation hot spots. Genes Dev 7:2556-2564. (Pubitemid 24021012)
83. Petris MJ, Mercer JF, Culvenor JG, Lockhart P, Gleeson PA, Camakaris J. 1996. Ligand-regulated transport of the Menkes copper P-type ATPase efflux pump from the Golgi apparatus to the plasma membrane: A novel mechanism of regulated trafficking. EMBO J 15:6084-6095. (Pubitemid 26397881)
84. Petrukhin K, Fischer SG, Pirastu M, Tanzi RE, Chernov I, Devoto M, Brzustowicz LM, Cayanis E, Vitale E, Russo JJ, Matseoane D, Boukhgalter B, Wasco W, Figus AL, Loudianos J, Cao A, Sternlieb I, Evgrafov O, Parano E, Pavone L, Warburton D, Ott J, Penchaszadeh GK, Scheinberg IH, Gilliam TC. 1993. Mapping, cloning and genetic characterization of the region containing the Wilson disease gene. Nat Genet 5:338-343. (Pubitemid 23351303)
85. Puglisi F, Aprile G, Minisini AM, Barbone F, Cataldi P, Tell G, Kelley MR, Damante G, Beltrami CA, Di LC. 2001. Prognostic significance of Ape1/ref-1 subcellular localization in non-small cell lung carcinomas. Anticancer Res 21:4041-4049.
86. Reliene R, Schiestl RH. 2007. Antioxidants suppress lymphoma and increase longevity in Atm-deficient mice. J Nutr 137:229S-232S (Pubitemid 46074948)
87. Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, Donaldson D, Goto J, O'Regan JP, Deng HX, Rahmani Z, Krizus A, Mckenna-yasek D, Cayabyab A, Gaston SM, Berger R, Tanzi RE, Halperin JJ, Herzfeldt B, van den Bergh R, Hung WY, Bird T, Deng G, Mulder DW, Smyth C, Laing NG, Soriano E, Pericak- Vance MA, Haines J, Rouleau GA, Gusella JS, Horvitz HR, Brown RH Jr. 1993. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362:59-62. (Pubitemid 23087289)
88. Ruppitsch W, Meisslitzer C, Weirich-Schwaiger H, Klocker H, Scheidereit C, Schweiger M, Hirsch-Kauffmann M. 1997. The role of oxygen metabolism for the pathological phenotype of Fanconi anemia. Hum Genet 99:710-719. (Pubitemid 27243747)
89. Russo MT, De Luca G, Degan P, Parlanti E, Dogliotti E, Barnes DE, Lindahl T, Yang H, Miller JH, Bignami M. 2004. Accumulation of the oxidative base lesion 8-hydroxyguanine in DNA of tumorprone mice defective in both the Myh and Ogg1 DNA glycosylases. Cancer Res 64:4411-4414. (Pubitemid 38856910)
90. Salonen JT, Alfthan G, Huttunen JK, Puska P. 1984. Association between serum selenium and the risk of cancer. Am J Epidemiol 120:342-349. (Pubitemid 14032081)
91. Scarabelli L, Giannoni P, Malfatto C, Bolognesi C, Cesarone CF. 1993. Relationship between poly(ADP-ribose) polymerase activity and DNA damage induced by zinc dithiocarbamates in mouse and rat liver. Mutat Res 302:1-6. (Pubitemid 23116769)
92. Schwerdtle T, Hamann I, Jahnke G, Walter I, Richter C, Parsons JL, Dianov GL, Hartwig A. 2007. Impact of copper on the induction and repair of oxidative DNA damage, poly(ADP-ribosyl)ation and PARP-1 activity. Mol Nutr Food Res 51:201-210. (Pubitemid 47083251)
93. Seo YR, Fishel ML, Amundson S, Kelley MR, Smith ML. 2002a. Implication of p53 in base excision DNA repair: In vivo evidence. Oncogene 21:731-737.
94. Seo YR, Kelley MR, Smith ML. 2002b. Selenomethionine regulation of p53 by a ref1-dependent redox mechanism. Proc Natl Acad Sci USA 99:14548-14553. (Pubitemid 35257708)
95. Shackelford RE, Fu Y, Manuszak RP, Brooks TC, Sequeira AP, Wang S, Lowery-Nordberg M, Chen A. 2006. Iron chelators reduce chromosomal breaks in ataxia-telangiectasia cells. DNA Repair (Amst) 5:1327-1336. (Pubitemid 44573931)
96. Shamberger RJ, Frost DV. 1969. Possible protective effect of selenium against human cancer. Can Med Assoc J 100:682
97. Shen CL, Song W, Pence BC. 2001. Interactions of selenium compounds with other antioxidants in DNA damage and apoptosis in human normal keratinocytes. Cancer Epidemiol Biomarkers Prev 10:385-390. (Pubitemid 32703224)
98. Shiloh Y. 2006. The ATM-mediated DNA-damage response: Taking shape. Trends Biochem Sci 31:402-410. (Pubitemid 44038916)
99. Siliciano JD, Canman CE, Taya Y, Sakaguchi K, Appella E, Kastan MB. 1997. DNA damage induces phosphorylation of the amino terminus of p53. Genes Dev 11:3471-3481. (Pubitemid 28023968)
100. Sjoblom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD, Mandelker D, Leary RJ, Ptak J, Silliman N, Szabo S, Buckhaults P, Farrell C, Meeh P, Markowitz SD, Willis J, Dawson D, Willson JK, Gazdar AF, Hartigan J, Wu L, Liu C, Parmigiani G, Park BH, Bachman KE, Papadopoulos N, Vogelstein B, Kinzler KW, Velculescu VE. 2006. The consensus coding sequences of human breast and colorectal cancers. Science 314:268-274. (Pubitemid 44571966)
101. Spallholz JE. 1997. Free radical generation by selenium compounds and their prooxidant toxicity. Biomed Environ Sci 10:260-270. (Pubitemid 127472088)
102. Spallholz JE, Shriver BJ, Reid TW. 2001. Dimethyldiselenide and methylseleninic acid generate superoxide in an in vitro chemiluminescence assay in the presence of glutathione: Implications for the anticarcinogenic activity of L-selenomethionine and L-Se-methylselenocysteine. Nutr Cancer 40:34-41. (Pubitemid 34037512)
103. Stewart MS, Spallholz JE, Neldner KH, Pence BC. 1999. Selenium compounds have disparate abilities to impose oxidative stress and induce apoptosis. Free Radic Biol Med 26:42-48.
104. Sundheim O, Talstadm VA, Vågboø CB, Slupphaug G, Krokan HE. 2008. AlkB demethylases flip out in different ways. DNA Repair 7:1916-1923.
105. Tanzi RE, Petrukhin K, Chernov I, Pellequer JL, Wasco W, Ross B, Romano DM, Parano E, Pavone L, Brzustowicz LM, Devoto M, Peppercorn J, Bush AI, Sternlieb I, Pirastu M, Gusella JF, Evgrafov O, Penchaszadeh GK, Honig B.Edelman IS, Soares MB, Scheinberg IH, Gilliam TC. 1993. The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene. Nat Genet 5:344-350. (Pubitemid 23351304)
106. Taylor CG, Bettger WJ, Bray TM. 1988. Effect of dietary zinc or copper deficiency on the primary free radical defense system in rats. J Nutr 118:613-621. (Pubitemid 18126595)
107. Theil EC. 2004. Iron, ferritin, and nutrition. Annu Rev Nutr 24:327-343.
108. Trzeciak AR, Nyaga SG, Jaruga P, Lohani A, Dizdaroglu M, Evans MK. 2004. Cellular repair of oxidatively induced DNA base lesions is defective in prostate cancer cell lines, PC-3 and DU-145 Carcinogenesis 25:1359-1370. (Pubitemid 39162702)
109. Vafa O, Wade M, Kern S, Beeche M, Pandita TK, Hampton GM, Wahl GM. 2002. c-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function. Mol Cell 9:1031-1044.
110. von Kobbe KC, May A, Grandori C, Bohr VA. 2004. Werner syndrome cells escape hydrogen peroxide-induced cell proliferation arrest. FASEB J 18:1970-1972. (Pubitemid 39602301)
111. Vulpe C, Levinson B, Whitney S, Packman S, Gitschier J. 1993. Isolation of a candidate gene for Menkes disease and evidence that it encodes a copper-transporting ATPase. Nat Genet 3:7-13. (Pubitemid 23063281)
112. Waga S, Stillman B. 1998. The DNA replication fork in eukaryotic cells. Annu Rev Biochem 67:721-751. (Pubitemid 28411143)
113. Wang P, Guliaev AB, Hang B. 2006. Metal inhibition of human N-methylpurine- DNA glycosylase activity in base excision repair. Toxicol Lett 166:237-247. (Pubitemid 44416552)
114. Wang W. 2007. Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins. Nat Rev Genet 8:735-748. (Pubitemid 47429206)
115. Weitzel F, Ursini F, Wendel A. 1990. Phospholipid hydroperoxide glutathione peroxidase in various mouse organs during selenium deficiency and repletion. Biochim Biophys Acta 1036:88-94. (Pubitemid 20355167)
116. Wong SH, Shih RS, Schoene NW, Lei KY. 2008. Zinc-induced G2/M blockage is p53 and p21 dependent in normal human bronchial epithelial cells. Am J Physiol Cell Physiol 294:C1342-C1349.
117. Xie Y, Yang H, CunananC,Okamoto K, ShibataD, Pan J, Barnes DE, Lindahl T, McIlhattonM, Fishel R, Miller JH. 2004. Deficiencies in mouseMyh and Ogg1 result in tumor predisposition and G to T mutations in codon 12 of the K-ras oncogene in lung tumors. Cancer Res 64:3096-3102. (Pubitemid 38581409)
118. Xu Y, Moore DH, Broshears J, Liu L, Wilson TM, Kelley MR. 1997. The apurinic/apyrimidinic endonuclease (APE/ref-1) DNA repair enzyme is elevated in premalignant and malignant cervical cancer. Anticancer Res 17:3713-3719. (Pubitemid 28014927)
119. Yang SW, Becker FF, Chan JYH. 1996. Inhibition of human DNA ligase 1 activity by zinc and cadmium and the fidelity of ligation. Enviorn Mol Mutagen 28:19-25. (Pubitemid 26273733)
120. Yant LJ, Ran Q, Rao L, Van Remmen H, Shibatani T, Belter JG, Motta L, Richardson A, Prolla TA. 2003. The selenoprotein GPX4 is essential for mouse development and protects from radiation and oxidative damage insults. Free Radic Biol Med 34:496-502. (Pubitemid 36140174)
121. Yu X, Hong S, Faustman EM. 2008. Cadmium-induced activation of stress signaling pathways, disruption of ubiquitin-dependent protein degradation and apoptosis in primary rat Sertoli cell-gonocyte cocultures. Toxicol Sci 104:385-396. (Pubitemid 352038260)
122. Zeng H, Combs GF Jr. 2008. Selenium as an anticancer nutrient: Roles in cell proliferation and tumor cell invasion. J Nutr Biochem 19:1-7. (Pubitemid 350213396)
123. Zhang QS, Eaton L, Snyder ER, Houghtaling S, Mitchell JB, Finegold M, Van Waes C, Grompe M. 2008. Tempol protects against oxidative damage and delays epithelial tumor onset in Fanconi anemia mice. Cancer Res 68:1601-1608. (Pubitemid 351346870)
124. Zhao R, Domann FE, Zhong W. 2006. Apoptosis induced by selenomethionine and methioninase is superoxide mediated and p53 dependent in human prostate cancer cells. Mol Cancer Ther 5:3275-3284. (Pubitemid 46092071)